共 50 条
- [22] Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells [J]. PLOS ONE, 2014, 9 (04):
- [24] A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors [J]. Investigational New Drugs, 2021, 39 : 1036 - 1046